Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay later under a partnership

TUESDAY, March 25, 2025 (HealthDay News) -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co., a Chinese pharmaceutical company.

(Reuters) -Danish drugmaker Novo Nordisk has secured the global rights to develop, manufacture and sell China-based United Laboratories International's weight-loss drug candidate in a deal worth up to $2 billion.

Los Angeles Dodgers shortstop Mookie Betts' status for Opening Day remains uncertain as he continues to deal with the illness that caused him to miss the Tokyo Series against the Chicago Cubs. Betts,

I’m practicing all day and my body’s just kind of eating itself,” Betts explained. “Literally every time I fuel my body, I throw it up, and I don’t know what to do ab

Days before the Dodgers’ home opener, Mookie Betts’ illness has turned into a troubling mystery, and his recent weight loss is raising red flags. Speaking to reporters after being scratched from Sunday night’s Freeway Series game against the Angels,